18 December 2017 - Jeff Bezos has eyed the pharmacy business for years without plunging in. The upside may be too big to ignore.
For months now, pharmacy and health benefits companies have fretted that they’re the next targets of Jeff Bezos’s disruption steamroller.
In September Amazon acquired Whole Foods Market, a grocery chain that could theoretically add drug counters to stores; a month later came word that the e-commerce giant had secured pharmacy licenses in more than a dozen states. Analysts issued dire warnings; shares see-sawed.